Error: Could not add to watchlist. X

Actelion Ltd

+ Watchlist
ATLN:VX
SIX Swiss Ex
144.20
CHF
1.30
0.91%
As of 03:12:00 ET on 08/03/2015.
Open
143.50
Day Range
143.30 - 144.50
Volume
20,731
Previous Close
142.90
52Wk Range
90.42 - 147.00
1 Yr Return
31.82%
Open
143.50
Day Range
143.30 - 144.50
Volume
20,731
Previous Close
142.90
52Wk Range
90.42 - 147.00
1 Yr Return
31.82%
YTD Return
25.64%
Current P/E Ratio (TTM)
34.35
Earnings per Share (CHF) (TTM)
4.16
Market Cap (b CHF)
16.309
Shares Outstanding (m)
114.128
Price/Sales (TTM)
8.06
Dividend Indicated Gross Yield
0.91%
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech
There are currently no news stories for this ticker. Please check back later.
Profile
Actelion Ltd is a biopharmaceutical company focused on the discovery, development and commercialization of drugs for diseases with significant unmet medical needs. The Company focuses in the field of pulmonary arterial hypertension (PAH) with treatments for diseases from WHO Functional Class (FC) II through to FC IV, with oral, inhaled and intravenous medications.
ADDRESS
Gewerbestrasse 16
Allschwil, 4123
Switzerland
PHONE
41-61-565-65-65
  • Jean-Paul Clozel
    CEO/Co-Founder
  • Andre C Muller
    Exec VP/CFO
  • Otto Schwarz
    Exec VP/COO
  • Nicholas Franco
    Exec VP/Chief Bus Dev Officer
  • Guy Braunstein
    Exec VP/Head:Clinical Dev
Show More